The effect of antiresorptives on bone quality. - Wikidata - awgldk - TriplyDB

The effect of antiresorptives on bone quality.

The effect of antiresorptives on bone quality.

http://www.wikidata.org/entity/Q33896122

about

Antiresorptive agents for the prevention of fractures after spinal cord injury Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.Deregulation of bone forming cells in bone diseases and anabolic effects of strontium-containing agents and biomaterials.The use of raloxifene in osteoporosis treatment.Changes in the degree of mineralization with osteoporosis and its treatment.Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients.No effect of risedronate on articular cartilage damage in the Dunkin Hartley guinea pig model of osteoarthritis.An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6.Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws.

P2860

Q24202102-DCF35A18-AD86-4807-8A79-4A14D885029B Q27025945-730700A4-D697-45A0-A63F-8EFCCE6F5FD6 Q36935525-65B50DE3-568E-4261-A632-1FA35D31C2D6 Q37706364-B6642B57-55FF-4103-B573-009A2805BF02 Q38092136-C40FEA32-F58F-4315-B8FF-E4810266F693 Q38221766-1F8C03EE-0CDE-4C51-9093-E2D63A4EF23A Q38599112-B0D4C40B-0354-4AF3-824E-BFE72C1E78E9 Q44210916-17F7C630-8039-4455-91D5-DCAFBAD6F3E8 Q44216694-2D1D76D5-B746-4583-A3D2-3E64D99DA538 Q52643913-1C9EDBBD-D4FE-403B-B3E3-0AE24EFAB806

P2860

The effect of antiresorptives on bone quality.

http://www.wikidata.org/entity/Q33896122

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

The effect of antiresorptives on bone quality.

@ast

The effect of antiresorptives on bone quality.

@en

type

label

The effect of antiresorptives on bone quality.

@ast

The effect of antiresorptives on bone quality.

@en

prefLabel

The effect of antiresorptives on bone quality.

@ast

The effect of antiresorptives on bone quality.

@en

P1433

Q33896122-E0F9995F-E4DE-4C99-BCBD-3AB42E2F8621

P1476

Q33896122-FC4B57E3-E9D6-4F03-9B0D-79E6BBD96013

P2093

Q33896122-DD04B343-0EB0-45A5-BF77-7F07379BAC4E

Q33896122-E45A3A43-5E73-42DB-86DD-B2A2022A4633

P2860

Q33896122-0098494F-AE46-4463-A586-4739EE530CB2

Q33896122-019EC817-2B7A-460E-A1F5-6E85F1DA945E

Q33896122-0695EED2-8595-4EBE-B9F0-32092FB5E8CB

Q33896122-0A6549DB-C36A-484E-BF8D-D97589D97531

Q33896122-1243E490-849D-4A7A-955A-A45914895E9E

Q33896122-152492B5-490A-4895-9996-5A365409321B

Q33896122-161551AC-84BC-4A58-A1B6-0F7982424AEB

Q33896122-179256DA-14D2-4191-B1DB-ED92544AE9BA

Q33896122-1B52D915-6931-40D3-8721-EA6CF6D84294

Q33896122-2313CF88-45C9-473F-8B48-75B36C705D7F

P2888

Q33896122-27301A68-80AA-4FA2-A0DA-A6CD72803ED8

P304

Q33896122-A8A971B5-E839-43FF-9645-3928591407DE

P31

Q33896122-0EAE04F3-BA8F-4EF7-83E1-FF19616B71CD

P356

Q33896122-5B2992AE-A3D2-4BDE-929F-014F0001199B

P407

Q33896122-8F18F0BE-67F7-49AF-8FAF-268833912EE5

P433

Q33896122-206A8A35-DA3D-4E06-9D97-CF5BE2720B98

P478

Q33896122-697A13DB-FE18-45E1-BE94-B6A7BA12E172

P577

Q33896122-C3F1DCEF-6AA0-442B-8444-3A77F53773C7

P5875

Q33896122-2EDB3A6F-75E6-4686-BFAA-2E277531A594

P6179

Q33896122-ECADE8B7-FC61-45F4-A836-D21E453A7DA2

P698

Q33896122-2DC226EA-6670-4267-BB5F-B60B8F220C22

P932

Q33896122-FA60AE15-6924-41F2-A9BA-7C265E88488D

P356

S11999-011-1909-8

P1433

Clinical Orthopaedics and Related Research

P1476

The effect of antiresorptives on bone quality.

@en

P2093

Laura Armas

http://www.w3.org/2001/XMLSchema#string

Robert R Recker

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Severely suppressed bone turnover: a potential complication of alendronate therapy.

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage

Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

Targeted and nontargeted remodeling.

Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.

P2888

s11999-011-1909-8

P304

2207-2214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11999-011-1909-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

469

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51117792

http://www.w3.org/2001/XMLSchema#string

P6179

1011614431

http://www.w3.org/2001/XMLSchema#string

P698

21562893

http://www.w3.org/2001/XMLSchema#string

P932

3126968

http://www.w3.org/2001/XMLSchema#string